Sibiude J. et al.
Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy.
AIDS 2020 oct 8

Hobson C.A. et al.
KPC beta-lactamases are permissive to insertions and deletions conferring substrate spectrum modifications and resistance to ceftazidime-avibactam.
Antimicrob. Agents Chemother. 2020 oct 5

Duprilot M. et al.
Success of Escherichia coli O25b:H4 ST131 clade C associated with a decrease in virulence.
Infect. Immun. 2020 Sep 28

Isernia V. et al.
SARS-COV2 infection in 30 HIV-infected patients followed-up in a French University Hospital.
Int. J. Infect. Dis. 2020 Sep 25

Massot M. et al.
Impact of loading dose of caspofungin in PK/PD target attainment for severe candidiasis infections in ICU patients – the CASPOLOAD study.
Antimicrob. Agents Chemother. 2020 Sep 21

Bailly S. et al.
Temporal dynamics of the fecal microbiota in veal calves in a 6-month field trial.
Animal Microbiome 2020 Sep 15

Petit M. et al.
Rapid detection and characterization of carbapenemases in Enterobacterales with a new modified carbapenem inactivation method: mCIMplus.
J. Clin. Microbiol. 2020 Sep 2

Fontaine C. et al.
Relationship between the composition of the intestinal microbiota and the tracheal and intestinal colonization by opportunistic pathogens in intensive care patients.
PLoS One. 2020 Aug 28

Denamur E. et al.
The population genetics of pathogenic Escherichia coli.
Nat. Rev. Microbiol. 2020 Aug 21

Grzelak L. et al.
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations.
Sci. Transl. Med. 2020 Aug 17

Rodrigues C. et al.
Community-acquired infection caused by the uncommon hypervirulent Klebsiella pneumoniae ST66-K2 lineage.
Microb. Genom. 2020 Aug 4

Hobson C.A. et al.
Urine zinc concentrations allow proper expression of metallo-β-lactamases in Enterobacteriaceae.
J. Antimicrob. Chemother. 2020 Jul 25

Atlani-Duault L. et al.
France’s COVID-19 response: balancing conflicting public health traditions.
Lancet 2020 Jul 25

Poline J. et al.
Systematic SARS-CoV-2 screening at hospital admission in children: a French prospective multicenter study.
Clin. Infect. Dis. 2020 Jul 25

Maisonnasse P. et al.
Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates.
Nature 2020 Jul 22

Lê M.P. et al.
Pharmacokinetics of lopinavir/ritonavir oral solution to treat COVID-19 in mechanically ventilated ICU patients.
J. Antimicrob. Chemother. 2020 Jul 20

Canovas J. et al.
Expression of CTX-M-15 limits the efficacy of ceftolozane/tazobactam against Escherichia coli in a high-inoculum murine peritonitis model.
Clin. Microbiol. Infect. 2020 Jul 2

Ouldali N. et al.
Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis.
Lancet Child Adolesc. Health 2020 Jul 2

Peiffer-Smadja N. et al.
Performance and impact of a multiplex PCR in ICU patients with ventilator-associated pneumonia or ventilated hospital-acquired pneumonia.
Crit. Care 2020 Jun 19

Gonçalves A. et al.
Timing of antiviral treatment initiation is critical to reduce SARS-CoV-2 viral load.
CPT Pharmacometrics Syst. Pharmacol. 2020 Jun 18

Kemble H. et al.
Flux, toxicity, and expression costs generate complex genetic interactions in a metabolic pathway.
Science Advances 2020 Jun 3

Lê M.P. et al.
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial.
J. Antimicrob. Chemother. 2020 May 30

Roujansky A. et al.
Analysis of paradoxical efficacy of carbapenems against carbapenemase-producing Escherichia coli in a murine model of lethal peritonitis.
Antimicrob. Agents Chemother. 2020 May 18

de Lastours V. et al.
Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it.
J. Antimicrob. Chemother. 2020 May 17

Jacquier H. et al.
Molecular epidemiology of Neisseria gonorrhoeae clinical isolates in Reunion and Mayotte.
Sex. Transm. Infect. 2020 May 4

Deslandes A. et al.
SARS-CoV-2 was already spreading in France in late december 2019.
Int. J. Antimicrob. Agents 2020 May 3

Delory T. et al.
A Computerized Decision Support System (CDSS) for antibiotic prescription in primary care-antibioclic: implementation, adoption and sustainable Use in the era of extended antimicrobial resistance.
J. Antimicrob. Chemother. 2020 May 1

Visseaux B. et al.
Evaluation of the QIAstat-Dx respiratory SARS-CoV-2 panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection.
J. Clin. Microbiol. 2020 Apr 27

Andremont O. et al.
Semi-quantitative cultures of throat and rectal swabs are efficient tests to predict ESBL-Enterobacterales ventilator-associated pneumonia in mechanically ventilated ESBL carriers.
Intensive Care Med. 2020 Apr 20

Jouvin-Marche E. et al.
French research strategy to tackle antimicrobial resistance.
Lancet 2020 Apr 18

Caméléna F. et al.
Genomic characterization of 16S rRNA methyltransferase-producing Escherichia coli isolates from the Parisian area, France.
J. Antimicrob. Chemother. 2020 Apr 16

Sallard E. et al.
Type 1 interferons as a potential treatment against COVID-19.
Antiviral Res. 2020 Apr 7

Lescure FX. et al.
Clinical and virological data of the first cases of COVID-19 in Europe: a case series.
Lancet Infect. Dis. 2020 Mar 27

Madelain V. et al.
Modeling favipiravir antiviral efficacy against emerging viruses: from animal studies to clinical trials.
CPT Pharmacometrics Syst. Pharmacol. 2020 Mar 20

Choudhury A. et al.
CRISPR/Cas9 recombineering-mediated deep mutational scanning of essential genes in Escherichia coli.
Mol. Syst. Biol. 2020 Mar 16

Marcelin AG. et al.
Frequency of capsid substitutions associated with GS-6207 in vitro resistance in HIV-1 from antiretroviral-naive and -experienced patients.
J. Antimicrob. Chemother 2020 Mar 10

Cointe A. et al.
Escherichia coli O80 hybrid pathotype strains producing Shiga toxin and ESBL: molecular characterization and potential therapeutic options.
J. Antimicrob. Chemother. 2020 Mar 1

Charpentier C. et al.
Pharmacovirological analyses of blood and male genital compartment in patients receiving dolutegravir + lamivudine dual therapy as a switch strategy (ANRS 167 LAMIDOL trial).
J. Antimicrob. Chemother. 2020 Feb 24

Riglet F. et al.
Bayesian individual dynamic predictions with uncertainty of longitudinal biomarkers and risks of survival events in a joint modelling framework: a comparison between Stan, Monolix, and NONMEM.
AAPS J. 2020 Feb 19

Peiffer-Smadja N. et al.
Machine learning in the clinical microbiology laboratory: has the time come for routine practice?
Clin. Microbiol. Infect. 2020 Feb 12

Hobson CA et al.
Impact of anticancer chemotherapy on the extension of beta-lactamase spectrum: an example with KPC-type carbapenemase activity towards ceftazidime-avibactam.
Sci. Rep. 2020 Jan 17

Tubiana S. et al.
Community-acquired bacterial meningitis in adults: in-hospital prognosis, long term disability and determinants of outcome in a multicentre prospective cohort.
Clin. Microbiol. Infect. 2020 Jan 9

Le Hingrat Q. et al.
Genetic variability of long terminal repeat region between HIV-2 groups impacts transcriptional activity.
J. Virol. 2020 Jan 8